ERAS Latest Headlines

Analysts Have Conflicting Sentiments on These Healthcare Companies: Capricor Therapeutics (CAPR), Ansell (OtherANSLF) and Erasca (ERAS)

at www.tipranks.com (Tue, 25-Aug 8:30 AM)

Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), Erasca (ERAS) and GlaxoSmithKline (GSK)

at www.tipranks.com (Tue, 25-Aug 7:30 AM)

Erasca Receives FDA Fast Track for ERAS-0015 in Pancreatic Cancer: Phase 1 Data Shows 57% Response Rate

Market Chameleon (Mon, 24-Aug 8:51 AM)

Erasca Wins FDA Fast Track for Pancreatic Therapy

at www.tipranks.com (Mon, 24-Aug 8:48 AM)

Erasca’s $550 Million Upsized Public Offering Bolsters R&D Ambitions: What Investors Need to Know

Market Chameleon (Tue, 14-Jul 7:31 AM)